Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Galectin Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Galectin Therapeutics Inc. | Option exercise | +22,268 | $1.23 | $27,390 |
| Jun 29, 2026 | Galectin Therapeutics Inc. | Open-market sale | −22,268 | $5.04 | $112,231 |
| Jun 26, 2026 | Galectin Therapeutics Inc. | Option exercise | +7,732 | $1.23 | $9,510 |
| Jun 26, 2026 | Galectin Therapeutics Inc. | Open-market sale | −7,732 | $5.00 | $38,660 |
| Dec 17, 2025 | Galectin Therapeutics Inc. | Option exercise | +20,000 | $1.98 | $39,600 |
| Dec 17, 2025 | Galectin Therapeutics Inc. | Open-market sale | −19,793 | $7.04 | $139,343 |
| Dec 17, 2025 | Galectin Therapeutics Inc. | Open-market sale | −4,706 | $7.04 | $33,130 |
| Dec 15, 2025 | Galectin Therapeutics Inc. | Option exercise | +8,417 | $4.16 | $35,015 |
| Dec 15, 2025 | Galectin Therapeutics Inc. | Open-market sale | −8,417 | $6.30 | $53,027 |
| Dec 12, 2025 | Galectin Therapeutics Inc. | Option exercise | +19,793 | $4.16 | $82,339 |
| Dec 12, 2025 | Galectin Therapeutics Inc. | Open-market sale | −19,793 | $6.27 | $124,102 |
| Dec 9, 2025 | Galectin Therapeutics Inc. | Option exercise | +16,790 | $4.16 | $69,846 |
| Dec 9, 2025 | Galectin Therapeutics Inc. | Open-market sale | −16,790 | $6.27 | $105,273 |
| Dec 8, 2025 | Galectin Therapeutics Inc. | Open-market sale | −4,000 | $6.01 | $24,040 |
| Dec 8, 2025 | Galectin Therapeutics Inc. | Option exercise | +35,000 | $2.86 | $100,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.